PhotoMedex (PHMD) shares were lower nearly 2% in recent trade after reporting Q1 earnings and sales that were short of analysts’ expectations.
PHMD is trading near the mid-point of the 52-week range between $10.51 and $17.05.
The provider of disease management and aesthetic solutions to dermatologists, aestheticians and consumers said its Q1 non-GAAP adjusted income was $0.23, missing the $0.24 average estimate from analysts polled by Capital IQ. Revenue fell to $50.1 million from $57.2 million, coming in below the $56.1 million consensus estimate.
Reported net loss was $345,000 or $0.02 per share compared to a profit of 7.2 million or $0.34 the year earlier.
Latest posts by Christina Langfold (see all)
- Wild Salamanders Are Highly Threatened By An Invasive Fungus - Apr 22, 2017
- Texas Registers Highest Number Of Mumps Cases In 20 Years - Apr 15, 2017
- The Mars Base Camp Is Lockheed’s Idea For A Space Future - Apr 5, 2017